Multi-modal feature selection with self-expression topological manifold for end-stage renal disease associated with mild cognitive impairment

Effectively selecting discriminative brain regions in multi-modal neuroimages is one of the effective means to reveal the neuropathological mechanism of end-stage renal disease associated with mild cognitive impairment (ESRDaMCI). Existing multi-modal feature selection methods usually depend on the Euclidean distance to measure the similarity between data, which tends to ignore the implied data manifold. A self-expression topological manifold based multi-modal feature selection method (SETMFS) is proposed to address this issue employing self-expression topological manifold. First, a dynamic brain functional network is established using functional magnetic resonance imaging (fMRI), after which the betweenness centrality is extracted. The feature matrix of fMRI is constructed based on this centrality measure. Second, the feature matrix of arterial spin labeling (ASL) is constructed by extracting the cerebral blood flow (CBF). Then, the topological relationship matrices are constructed by calculating the topological relationship between each data point in the two feature matrices to measure the intrinsic similarity between the features, respectively. Subsequently, the graph regularization is utilized to embed the self-expression model into topological manifold learning to identify the linear self-expression of the features. Finally, the selected well-represented feature vectors are fed into a multicore support vector machine (MKSVM) for classification. The experimental results show that the classification performance of SETMFS is significantly superior to several state-of-the-art feature selection methods, especially its classification accuracy reaches 86.10%, which is at least 4.34% higher than other comparable methods. This method fully considers the topological correlation between the multi-modal features and provides a reference for ESRDaMCI auxiliary diagnosis

An effective feature selection using improved marine predators algorithm for Alzheimer’s disease classification

Alzheimer’s disease (AD) is an irremediable neurodegenerative illness developed by the fast deterioration of brain cells. AD is mostly common in elder people and it extremely disturbs the physical and mental health of patients, therefore early detection is essential to prevent AD development. However, the precise detection of AD and mild cognitive impairment (MCI) is difficult during classification. In this paper, the Residual network i.e., ResNet-18 is used for extracting the features, and the proposed improved marine predators algorithm (IMPA) is developed for choosing the optimum features to perform an effective classification of AD. The multi-verse optimizer (MVO) used in the IMPA helps to balance exploration and exploitation, which leads to the selection of optimal relevant features. Further, the classification of AD is accomplished using the multiclass support vector machine (MSVM). Open access series of imaging studies-1 (OASIS-1) and Alzheimer disease neuroimaging initiative (ADNI) datasets are used to evaluate the IMPA-MSVM method. The performance of the IMPA-MSVM method is analyzed using accuracy, sensitivity, specificity, positive predictive value (PPV) and matthews correlation coefficient (MCC). The existing methods such as the deep learning-based segmenting method using SegNet (DLSS), mish activation function (MAF) with spatial transformer network (STN) and BrainNet2D are used to evaluate the IMPA-MSVM method. The accuracy of IMPA-MSVM for the ADNI dataset is 98.43% which is more when compared to the DLSS and MAF-STN

Recent Advances of Manifold Regularization

Semi-supervised learning (SSL) that can make use of a small number of labeled data with a large number of unlabeled data to produce significant improvement in learning performance has been received considerable attention. Manifold regularization is one of the most popular works that exploits the geometry of the probability distribution that generates the data and incorporates them as regularization terms. There are many representative works of manifold regularization including Laplacian regularization (LapR), Hessian regularization (HesR) and p-Laplacian regularization (pLapR). Based on the manifold regularization framework, many extensions and applications have been reported. In the chapter, we review the LapR and HesR, and we introduce an approximation algorithm of graph p-Laplacian. We study several extensions of this framework for pairwise constraint, p-Laplacian learning, hypergraph learning, etc

Evolutionary Computation

This book presents several recent advances on Evolutionary Computation, specially evolution-based optimization methods and hybrid algorithms for several applications, from optimization and learning to pattern recognition and bioinformatics. This book also presents new algorithms based on several analogies and metafores, where one of them is based on philosophy, specifically on the philosophy of praxis and dialectics. In this book it is also presented interesting applications on bioinformatics, specially the use of particle swarms to discover gene expression patterns in DNA microarrays. Therefore, this book features representative work on the field of evolutionary computation and applied sciences. The intended audience is graduate, undergraduate, researchers, and anyone who wishes to become familiar with the latest research work on this field

Vision transformers for the prediction of mild cognitive impairment to Alzheimer’s disease progression using mid-sagittal sMRI

BackgroundAlzheimer’s disease (AD) is one of the most common causes of neurodegenerative disease affecting over 50 million people worldwide. However, most AD diagnosis occurs in the moderate to late stage, which means that the optimal time for treatment has already passed. Mild cognitive impairment (MCI) is an intermediate state between cognitively normal people and AD patients. Therefore, the accurate prediction in the conversion process of MCI to AD may allow patients to start preventive intervention to slow the progression of the disease. Nowadays, neuroimaging techniques have been developed and are used to determine AD-related structural biomarkers. Deep learning approaches have rapidly become a key methodology applied to these techniques to find biomarkers.MethodsIn this study, we aimed to investigate an MCI-to-AD prediction method using Vision Transformers (ViT) to structural magnetic resonance images (sMRI). The Alzheimer’s Disease Neuroimaging Initiative (ADNI) database containing 598 MCI subjects was used to predict MCI subjects’ progression to AD. There are three main objectives in our study: (i) to propose an MRI-based Vision Transformers approach for MCI to AD progression classification, (ii) to evaluate the performance of different ViT architectures to obtain the most advisable one, and (iii) to visualize the brain region mostly affect the prediction of deep learning approach to MCI progression.ResultsOur method achieved state-of-the-art classification performance in terms of accuracy (83.27%), specificity (85.07%), and sensitivity (81.48%) compared with a set of conventional methods. Next, we visualized the brain regions that mostly contribute to the prediction of MCI progression for interpretability of the proposed model. The discriminative pathological locations include the thalamus, medial frontal, and occipital—corroborating the reliability of our model.ConclusionIn conclusion, our methods provide an effective and accurate technique for the prediction of MCI conversion to AD. The results obtained in this study outperform previous reports using the ADNI collection, and it suggests that sMRI-based ViT could be efficiently applied with a considerable potential benefit for AD patient management. The brain regions mostly contributing to prediction, in conjunction with the identified anatomical features, will support the building of a robust solution for other neurodegenerative diseases in future

Biometric data and machine learning methods in the diagnosis and monitoring of neurodegenerative diseases: a review

Представлен обзор неинвазивных биометрических методов выявления и прогнозирования развития нейродегенеративных заболеваний. Дан анализ различных модальностей, используемых для диагностики и мониторинга. Рассмотрены такие модальности, как рукописные данные, электроэнцефалограмма, речь, походка, движение глаз, а также использование композиций данных модальностей. Проведен подробный анализ современных методов и систем принятия решений, основанных на машинном обучении. Представлены наборы данных, методы предобработки, модели машинного обучения, оценки точности при диагностике заболеваний. В заключении рассмотрены текущие открытые проблемы и будущие перспективы исследований в данном направлении.Работа выполнена при поддержке Российского на-учного фонда (проект № 22-21-00021)

Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: a systematic review

Introduction Artificial intelligence (AI) and neuroimaging offer new opportunities for diagnosis and prognosis of dementia. Methods We systematically reviewed studies reporting AI for neuroimaging in diagnosis and/or prognosis of cognitive neurodegenerative diseases. Results A total of 255 studies were identified. Most studies relied on the Alzheimer's Disease Neuroimaging Initiative dataset. Algorithmic classifiers were the most commonly used AI method (48%) and discriminative models performed best for differentiating Alzheimer's disease from controls. The accuracy of algorithms varied with the patient cohort, imaging modalities, and stratifiers used. Few studies performed validation in an independent cohort. Discussion The literature has several methodological limitations including lack of sufficient algorithm development descriptions and standard definitions. We make recommendations to improve model validation including addressing key clinical questions, providing sufficient description of AI methods and validating findings in independent datasets. Collaborative approaches between experts in AI and medicine will help achieve the promising potential of AI tools in practice. Highlights There has been a rapid expansion in the use of machine learning for diagnosis and prognosis in neurodegenerative disease Most studies (71%) relied on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with no other individual dataset used more than five times There has been a recent rise in the use of more complex discriminative models (e.g., neural networks) that performed better than other classifiers for classification of AD vs healthy controls We make recommendations to address methodological considerations, addressing key clinical questions, and validation We also make recommendations for the field more broadly to standardize outcome measures, address gaps in the literature, and monitor sources of bia

Pacific Symposium on Biocomputing 2023

The Pacific Symposium on Biocomputing (PSB) 2023 is an international, multidisciplinary conference for the presentation and discussion of current research in the theory and application of computational methods in problems of biological significance. Presentations are rigorously peer reviewed and are published in an archival proceedings volume. PSB 2023 will be held on January 3-7, 2023 in Kohala Coast, Hawaii. Tutorials and workshops will be offered prior to the start of the conference.PSB 2023 will bring together top researchers from the US, the Asian Pacific nations, and around the world to exchange research results and address open issues in all aspects of computational biology. It is a forum for the presentation of work in databases, algorithms, interfaces, visualization, modeling, and other computational methods, as applied to biological problems, with emphasis on applications in data-rich areas of molecular biology.The PSB has been designed to be responsive to the need for critical mass in sub-disciplines within biocomputing. For that reason, it is the only meeting whose sessions are defined dynamically each year in response to specific proposals. PSB sessions are organized by leaders of research in biocomputing's 'hot topics.' In this way, the meeting provides an early forum for serious examination of emerging methods and approaches in this rapidly changing field